A synthetic peptide for use as a blocking control in assays to test for specificity of RNF40 antibody, Alternative Names: RNF40 control peptide, RNF40 antibody Blocking Peptide, Anti-RNF40 Blocking Peptide, Ring Finger Protein 40 Blocking Peptide, BRE1B Blocking Peptide, DKFZp686K191 Blocking Peptide, KIAA0661 Blocking Peptide, MGC13051 Blocking Peptide, RBP95 Blocking Peptide, STARING Blocking Peptide, RNF40, RNF-40, RNF 40, RNF-40 Blocking Peptide, RNF 40 Blocking Peptide
RNF40
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
RNF40
(Ring Finger Protein 40, E3 Ubiquitin Protein Ligase (RNF40))
Synonyme
AI848422 Peptide, mKIAA0661 Peptide, BRE1B Peptide, RBP95 Peptide, STARING Peptide, ring finger protein 40 Peptide, RNF40 Peptide, Rnf40 Peptide
Hintergrund
RNF40 contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery.